Clinical Trials List
Protocol NumberNTUH107-003747
Not yet recruiting
2017-08-01 - 2019-06-30
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- TA-FU CHEN Division of Neurology
- RUOH-FANG YEN Division of Nuclear Medicine
- Ming-Jang Chiu Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
40 participants
